Observational studyCardiovascular diabetology2021

Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching.

What the trial testedas reported · 922 people · 2021

Not counted

−39%−58% to −10%

Bigger than 9 in 10 for all-cause mortality

As reported

OR 0.61, 95% CI 0.42–0.90 · the paper's word: All-cause mortality

Not counted

−65%−79% to −39%

Bigger than almost all for all-cause mortality

As reported

OR 0.35, 95% CI 0.21–0.61 · the paper's word: All-cause mortality

the abstract, start to end

… compared to the non-statin group (OR, 0.61; 95% CI, 0.42-0.90; p = 0.01).

… statins had reduced mortality (OR, 0.35; 95% CI, 0.21-0.61; p < 0.001).

← favours treatmentfavours comparator →

could be chance

All-cause mortality

OR 0.610.42–0.90

All-cause mortality

OR 0.350.21–0.61

StatinsAll-cause mortality

1 / 3

2021

2022

2023

2024

2025

2026

this paperpooled itcites it